Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Tecsys named Challenger in Gartner's Magic Quadrant for Warehouse Management Systems for 15th time.

Market News
04 May 2026
PRNewsWire
View Source
Bullish
pluang ai news

Tecsys Inc., a supply chain management company, has been recognized by Gartner as a Challenger in the Magic Quadrant for Warehouse Management Systems for the 15th time. This recognition highlights Tecsys' strong Completeness of Vision and Ability to Execute, particularly in complex warehouse operations and healthcare sectors. Their Warehouse Management System, built on the Tecsys Elite platform, supports automation, robotics, labor optimization, and real-time visibility to improve efficiency and accuracy. This continued recognition reflects Tecsys' investment in technology and AI-driven insights to enhance operational workflows.

More News

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

Global Bioprocess Automation Software market to reach $6.19B by 2035 with 14% CAGR, driven by personalized medicine and scalable production.

The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...

Market News
Bullish
1 hour ago
Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.

Microneedle drug delivery market to double to $14.37B by 2035, driven by pain-free therapies and vaccine tech.

The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...

Market News
Bullish
2 hours ago
Novartis unveils new Phase III data advancing kidney disease treatments at ERA 2026.

Novartis unveils new Phase III data advancing kidney disease treatments at ERA 2026.

Novartis announced it will present 15 abstracts at the European Renal Association Congress 2026, highlighting late-stage clinical data for kidney disease treatments including Vanrafia (atrasentan), Fabhalta (iptacopan), and zigakibart for IgA nephrop...

Market News
Bullish
4 hours ago
Render token jumps 13% as on-chain activity and AI demand boost trader interest.

Render token jumps 13% as on-chain activity and AI demand boost trader interest.

Render's token price surged to $2.25, rising 13.16% in 24 hours and 24.16% over a week, driven by a 12-week high in daily active addresses and new wallets. Increased derivatives volume and open interest indicate stronger trader activity, while Render...

Technical Signals
Bullish
4 hours ago
XRP falls below $1.35, eyes key $1.30 support amid triangle breakdown fears

XRP falls below $1.35, eyes key $1.30 support amid triangle breakdown fears

XRP slipped below the $1.35 level after failing to break above $1.36, signaling short-term bearish momentum within a tight trading range. Traders are now focused on the critical $1.30 to $1.31 support zone, where a decisive breakdown could lead to fu...

Technical Signals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App